Fig. 6From: Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau diseaseHypothesis summarizing the propranolol mechanism involved in haemangioblastoma cells. As a β-blocker, propranolol would reverse three main targets promoting the cessation of division and apoptosis, anti-angiogenesis, and vasoconstrictionBack to article page